A single-session slide in a thinly traded nano-cap biotech rarely tells the full story, and CytoMed Therapeutics (NASDAQ: GDTC) is a clear example. The Singapore-based cell-therapy developer, whose shares eased about 8.7% to around $0.79, carries a marketCapitalizationof roughly $9 million, small enough that …
● GE HealthCare is one of the world's largest medical technology companies, spanning imaging such as CT, MRI and molecular imaging, along with ultrasound, patient care solutions and pharmaceutical diagnostics.
● The roughly 26% advance does not map to a single, clearly identifiable public catalyst disclosed on or around the trading day.
Global Medical Products Holdings, Inc. (OTC:GMDP) sits at the most obscure end of the public-market spectrum. Quoted at essentially a hundredth of a cent with aMarket Valueof only a few dozen dollars in the last closing session, GMDP is a nano-cap ticker with a …
Yubo International Biotech is a China-focused health and personal-care company built around endometrial stem-cell research, development and application. It markets consumer and wellness products under the VIVCELL brand, spanning respiratory, skincare, hair-care and beverage lines, and offers stem-cell testing and health-management consulting services. The …
Seres Therapeutics is a Nasdaq-listed clinical-stage company pioneering microbiome therapeutics, live bacterial consortia designed to treat disease by modulating the gut. Its former commercial product, VOWST, was divested to Nestlé Health Science, and Seres now centers its future on SER-155, a cultivated microbiome candidate. …
Eco-Growth Strategies is a Hawaii-basedBusinessnow centered on premium bottled water production and distribution, having historically described itself as a provider of design-build infrastructure services, including telecommunications work. The company trades on the U.S. over-the-counter market, not a national exchange. Through 2026 it has publicized …
Organogenesis is a regenerative-medicine company focused on advanced wound care and surgical and sports medicine, with a portfolio that has long included skin-substitute and tissue products such as Apligraf and Dermagraft. In the second quarter of 2026, the company reported revenue of $42.8 million, …
Few tickers illustrate the hazards of nano-cap trading better than Greater Cannabis Co Inc (OTC:GCAN). The share registry still lists the name Greater Cannabis Co Inc, yet theBusinessbehind it has quietly reinvented itself in 2026, walking away from cannabinoid research and toward financial services …
America Great Health describes itself as a biotechnology company focused on theResearch and Developmentof protein and peptide small-molecule drugs, alongside interests spanning AI-based diagnostic devices, cell therapy and regenerative medicine. The company is based in Alhambra, California, and was formerly known as Crown Marketing …